We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPH
3626
DELISTED
UpHealth, Inc.
UPH
$98K ﹤0.01%
60,356
+451
+0.8% +$1.75K
AHG
3627
Akso Health Group
AHG
$1.23B
$97K ﹤0.01%
257,498
-76,800
-23% -$39.2K
SIFY
3628
Sify Technologies
SIFY
$1.14B
$97K ﹤0.01%
14,000
+10,833
+342% +$95.5K
QXO
3629
QXO Inc
QXO
$15.9B
$97K ﹤0.01%
4,100
+109
+3% +$3.22K
TBIO
3630
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$97K ﹤0.01%
4,506
-3,561
-44% -$96.8K
ACHV icon
3631
Achieve Life Sciences
ACHV
$664M
$96K ﹤0.01%
39,200
+500
+1% +$1.28K
CNVS icon
3632
Cineverse
CNVS
$63.5M
$96K ﹤0.01%
12,341
-614
-5% -$5.85K
CODA icon
3633
Coda Octopus Group
CODA
$118M
$96K ﹤0.01%
+13,928
New +$88.1K
WPRT
3634
Westport Fuel Systems
WPRT
$35M
$96K ﹤0.01%
12,377
-68,474
-85% -$587K
DMTK
3635
DELISTED
DermTech, Inc. Common Stock
DMTK
$96K ﹤0.01%
+54,000
New +$144K
CPSH icon
3636
CPS Technologies
CPSH
$81.9M
$95K ﹤0.01%
35,500
-18,333
-34% -$55.6K
PAVS icon
3637
Paranovus Entertainment Technology
PAVS
$4.23M
0
PLUR icon
3638
Pluri
PLUR
$16.8M
$95K ﹤0.01%
12,575
-475
-4% -$3.09K
ASLN
3639
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$95K ﹤0.01%
6,563
-2,582
-28% -$49.8K
CATX icon
3640
Perspective Therapeutics
CATX
$342M
$94K ﹤0.01%
37,913
+700
+2% +$2.31K
XFOR icon
3641
X4 Pharmaceuticals
XFOR
$405M
$94K ﹤0.01%
3,160
-4,913
-61% -$233K
EFTR
3642
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$94K ﹤0.01%
8,796
+980
+13% +$12.4K
THRX
3643
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$94K ﹤0.01%
+18,800
New +$110K
AGPU
3644
Axe Compute Inc
AGPU
$103M
$93K ﹤0.01%
1,009
+214
+27% +$21.2K
ORGS
3645
DELISTED
Orgenesis Inc. Common Stock
ORGS
$93K ﹤0.01%
4,750
-350
-7% -$5.96K
FRLN
3646
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$93K ﹤0.01%
13,093
-1,174
-8% -$11.2K
CORR
3647
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$93K ﹤0.01%
44,577
+21,677
+95% +$47.2K
LIQT icon
3648
LiqTech
LIQT
$21.6M
$92K ﹤0.01%
30,235
-24,965
-45% -$80.1K
NMTR
3649
DELISTED
9 Meters Biopharma
NMTR
$92K ﹤0.01%
73,168
-9,942
-12% -$22.7K
ARMP icon
3650
Armata Pharmaceuticals
ARMP
$172M
$91K ﹤0.01%
73,696
+3,900
+6% +$10.2K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.